Avidity Biosciences (RNA)
(Delayed Data from NSDQ)
$29.50 USD
+0.78 (2.72%)
Updated May 17, 2024 04:00 PM ET
After-Market: $29.26 -0.24 (-0.81%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.76 | 0.00% |
Earnings Summary
For their last quarter, Avidity Biosciences (RNA) reported earnings of -$0.79 per share, beating the Zacks Consensus Estimate of $-0.81 per share. This reflects a positive earnings surprise of 2.47%. Look out for RNA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.76 per share, reflecting a year-over-year decrease of 15.15%.
Earnings History
Price & Consensus
Zacks News for RNA
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
RNA: What are Zacks experts saying now?
Zacks Private Portfolio Services